Ceftolozane CAS# 689293-68-3 5-氨基-2-{(6R,7R)-7-(2Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-(1-羧基-1-甲基氧基)亚胺乙酰胺-2-羧基-8-氧基-5-硫胺-1-氮基环4.2.0oct-2-烯-3-甲基甲基}-4-{(2-氨基乙基)氨基酰胺}-1-甲基-1H-吡氮唑-2-铀

Ceftolozane, also known as FR-264,205 and CXA-101; is an antibiotic drug from the cephalosporin family, approved for the treatment of infections with gram-negative bacteria, or gram-positive bacteria. Ceftolozane is of great benefit due to its ability to target bacteria that have become resistant to conventional antibiotics. Ceftolozane is combined with the β-lactamase inhibitor tazobactam, as multi-drug resistant bacterial infections will generally show resistance to all β-lactam antibiotics unless this enzyme is inhibited.